By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Tekla Life Sciences Investors

Tekla Life Sciences Investors (HQL)

NYSE Currency in USD
$13.05
+$0.09
+0.69%
Last Update: 16 Jul 2025, 20:00
$376.78M
Market Cap
0.00
P/E Ratio (TTM)
13.18%
Forward Dividend Yield
$10.55 - $15.90
52 Week Range

HQL Stock Price Chart

Explore Tekla Life Sciences Investors interactive price chart. Choose custom timeframes to analyze HQL price movements and trends.

There is nothing to show.

HQL Company Profile

Discover essential business fundamentals and corporate details for Tekla Life Sciences Investors (HQL) to support your stock research and investment decisions.

Sector

Financial Services

Industry

Asset Management

IPO Date

1 May 1992

Employees

CEO

Daniel R. Omstead M.S,

Description

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

HQL Financial Timeline

Browse a chronological timeline of Tekla Life Sciences Investors corporate events including earnings releases, dividend announcements, and stock splits.

Earnings released on 9 Jun 2025

Dividend declared on 12 May 2025

A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 30 Jun 2025.

Dividend declared on 11 Feb 2025

A dividend of $0.47 per share was announced, adjusted to $0.47. The dividend was paid on 31 Mar 2025.

Earnings released on 9 Dec 2024

EPS came in at $1.22, while revenue for the quarter reached $1.91M.

Dividend declared on 21 Nov 2024

A dividend of $0.50 per share was announced, adjusted to $0.50. The dividend was paid on 10 Jan 2025.

Dividend declared on 9 Aug 2024

A dividend of $0.49 per share was announced, adjusted to $0.49. The dividend was paid on 30 Sept 2024.

Earnings released on 6 Aug 2024

EPS came in at $1.84, while revenue for the quarter reached $2.07M.

Dividend declared on 9 May 2024

A dividend of $0.48 per share was announced, adjusted to $0.48. The dividend was paid on 28 Jun 2024.

Dividend declared on 9 Feb 2024

A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 28 Mar 2024.

Earnings released on 11 Dec 2023

EPS came in at -$0.43, while revenue for the quarter reached $29.56M.

Dividend declared on 9 Nov 2023

A dividend of $0.30 per share was announced, adjusted to $0.30. The dividend was paid on 10 Jan 2024.

Dividend declared on 15 Aug 2023

A dividend of $0.32 per share was announced, adjusted to $0.32. The dividend was paid on 29 Sept 2023.

Dividend declared on 15 May 2023

A dividend of $0.32 per share was announced, adjusted to $0.32. The dividend was paid on 30 Jun 2023.

Earnings released on 31 Mar 2023

EPS came in at $1.29, while revenue for the quarter reached $1.93M.

Dividend declared on 15 Feb 2023

A dividend of $0.33 per share was announced, adjusted to $0.33. The dividend was paid on 31 Mar 2023.

Dividend declared on 15 Nov 2022

A dividend of $0.31 per share was announced, adjusted to $0.31. The dividend was paid on 30 Dec 2022.

Earnings released on 30 Sept 2022

EPS came in at -$1.10, while revenue for the quarter reached $21.69M.

Dividend declared on 17 Aug 2022

A dividend of $0.31 per share was announced, adjusted to $0.31. The dividend was paid on 30 Sept 2022.

Dividend declared on 18 May 2022

A dividend of $0.35 per share was announced, adjusted to $0.35. The dividend was paid on 30 Jun 2022.

Earnings released on 31 Mar 2022

EPS came in at -$3.03, while revenue for the quarter reached $10.17M.

Dividend declared on 17 Feb 2022

A dividend of $0.39 per share was announced, adjusted to $0.39. The dividend was paid on 31 Mar 2022.

Dividend declared on 15 Nov 2021

A dividend of $0.42 per share was announced, adjusted to $0.42. The dividend was paid on 31 Dec 2021.

Earnings released on 30 Sept 2021

EPS came in at $1.34, while revenue for the quarter reached $15.98M.

Dividend declared on 18 Aug 2021

A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 30 Sept 2021.

Dividend declared on 19 May 2021

A dividend of $0.41 per share was announced, adjusted to $0.41. The dividend was paid on 30 Jun 2021.

Earnings released on 31 Mar 2021

EPS came in at $1.30, while revenue for the quarter reached $29.03M.

Dividend declared on 17 Feb 2021

A dividend of $0.43 per share was announced, adjusted to $0.43. The dividend was paid on 31 Mar 2021.

Dividend declared on 22 Dec 2020

A dividend of $0.02 per share was announced, adjusted to $0.02. The dividend was paid on 6 Jan 2021.

Dividend declared on 17 Nov 2020

A dividend of $0.40 per share was announced, adjusted to $0.40. The dividend was paid on 31 Dec 2020.

Earnings released on 30 Sept 2020

EPS came in at $3.91, while revenue for the quarter reached $16.50M.

Dividend declared on 18 Aug 2020

A dividend of $0.41 per share was announced, adjusted to $0.41. The dividend was paid on 30 Sept 2020.

HQL Stock Performance

Access detailed HQL performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

There is nothing to show.
HQL
Company Name
Exchange
Market Currency
Report Currency
Price
Price Change
Percentage Change
50-Day Average Price
200-Day Average Price
Trading Volume
Market Capitalization
HQL
2025
2024
2023
2022
2021
Revenue
Gross Profit
Earnings Before Interest and Taxes (EBIT)
Net Income
Total Current Assets
Total Assets
Total Liabilities
Net Debt
Total Equity
Cash Flow from Operating
Cash Flow from Investing
Cash Flow from Financing
Free Cash Flow

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More